Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non-Small Cell Lung Cancer

6 references·1 citing·33 second hop

FromToDepth

this work references cited by second hop

References

1992How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1,581 cited
2004Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?790 cited
2008Evaluation of Trends in the Cost of Initial Cancer Treatment388 cited
2000Systematic Overview of Cost-Utility Assessments in Oncology296 cited
2006Statistical Analysis of Cost‐effectiveness Data155 cited
2008The Potential Clinical and Economic Outcomes of Pharmacogenomic Approaches to EGFR-Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer86 cited

Cited by

2011Cost‐effectiveness of epidermal growth factor receptor mutation testing and first‐line treatment with gefitinib for patients with advanced adenocarcinoma of the lung64 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work